Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients

Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients

Abstract DMD is a rare disorder characterized by progressive muscle degeneration and premature death. Therapy development is delayed by difficulties to monitor efficacy non‐invasively in clinical trials. In this study, we used RNA‐sequencing to describe the pathophysiological changes in skeletal mus...

Full description

Bibliographic Details
Main Authors: Mirko Signorelli, Mitra Ebrahimpoor, Olga Veth, Kristina Hettne, Nisha Verwey, Raquel García‐Rodríguez, Christa L Tanganyika‐deWinter, Luz B Lopez Hernandez, Rosa Escobar Cedillo, Benjamín Gómez Díaz, Olafur T Magnusson, Hailiang Mei, Roula Tsonaka, Annemieke Aartsma‐Rus, Pietro Spitali
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:EMBO Molecular Medicine
Subjects:
biomarkers
Duchenne muscular dystrophy
dystrophinopathies
RNA‐seq
Online Access:https://doi.org/10.15252/emmm.202013328

Internet

https://doi.org/10.15252/emmm.202013328

Similar Items